Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer.
暂无分享,去创建一个
Paul Ziprin | P. Ziprin | P. Tekkis | Emile Tan | Nikos Gouvas | R John Nicholls | Evaghelos Xynos | Paris P Tekkis | E. Tan | E. Xynos | R. J. Nicholls | N. Gouvas
[1] H. Beger,et al. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts , 2000, Langenbeck's Archives of Surgery.
[2] L E Moses,et al. Estimating Diagnostic Accuracy from Multiple Conflicting Reports , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[3] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.
[4] A. Verbeek,et al. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. , 1992, British Journal of Cancer.
[5] J. Arnaud,et al. Carcinoembryonic antigen (CEA) in diagosis and prognosis of colorectal carcinoma , 1980, Diseases of the colon and rectum.
[6] J. Kievit,et al. Utility and cost of carcinoemhryonic antigen monitoring in colon cancer follow‐up evaluation: A markove analysis , 1990, Cancer.
[7] A. Nicolini,et al. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. , 1995, Cancer detection and prevention.
[8] O. Nilsson,et al. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] K. Okuno,et al. Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques , 1996, Diseases of the colon and rectum.
[10] R. A. Baker,et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer , 1994, Diseases of the colon and rectum.
[11] Phil Gold,et al. SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.
[12] O. Nanni,et al. Free DNA and Carcinoembryonic Antigen Serum Levels: An Important Combination for Diagnosis of Colorectal Cancer , 2006, Clinical Cancer Research.
[13] E. Seregni,et al. The Role of Serum Carcinoembryonic Antigen (CEA) in the Management of Patients with Colorectal Carcinoma: The Experience of the Istituto Tumori of Milan , 1992, International Journal of Biological Markers.
[14] H. Körner,et al. Diagnostic Accuracy of Serum-Carcinoembryonic Antigen in Recurrent Colorectal Cancer: A Receiver Operating Characteristic Curve Analysis , 2007, Annals of Surgical Oncology.
[15] A. Norman,et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] E. Schlichting,et al. Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients. , 1992, Scandinavian journal of gastroenterology.
[17] J. Piqué,et al. Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA. , 1994, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[18] Brigham,et al. The use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy , 1980, Cancer.
[19] J. Reed,et al. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma , 1997, Diseases of the colon and rectum.
[20] M. O'brien,et al. Circulating CEA levels in patients with fulminant hepatitis , 1982, Digestive Diseases and Sciences.
[21] O. Topolcan,et al. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. , 2000, Anticancer research.
[22] F. Guadagni,et al. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation. , 2001, Anticancer Research.
[23] A. Awwad,et al. Serial determinations of serum CEA in monitoring management of patients with colorectal carcinoma. , 1990, Oncology.
[24] S. Walter,et al. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data , 2002, Statistics in medicine.
[25] J. Kievit. Follow-up of patients with colorectal cancer: numbers needed to test and treat. , 2002, European journal of cancer.
[26] J. Y. Wang,et al. Value of carcinoembryonic antigen in the management of colorectal cancer , 1994, Diseases of the colon and rectum.
[27] Y. Shiau,et al. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer. , 2001, Anticancer research.
[28] J. O'fallon,et al. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer , 1986, Cancer.
[29] G. Guyatt,et al. Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients? , 1994 .
[30] C. Kelly,et al. Colorectal cancer: Principles of postoperative follow‐up , 1992, Cancer.
[31] M. O'brien,et al. Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. , 1981, The American journal of medicine.
[32] Y. Park,et al. Prognostic Effect of Perioperative Change of Serum Carcinoembryonic Antigen Level: A Useful Tool for Detection of Systemic Recurrence in Rectal Cancer , 2006, Annals of Surgical Oncology.
[33] G. Guyatt,et al. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. , 1994, JAMA.
[34] S. Greco,et al. Monitoring carcinoembryonic antigen in colorectal cancer: Is it still useful? , 1998, Surgery Today.
[35] N. Mulder,et al. Value and cost of follow‐up after adjuvant treatment of patients with Dukes' C colonic cancer , 2001, The British journal of surgery.
[36] Toyoki Kobayashi,et al. Tumor angiogenesis predicts recurrence with normal serum carcinoembryonic antigen in advanced rectal carcinoma patients , 2010, Surgery Today.
[37] Gordon H. Guyatt,et al. Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test A. Are the Results of the Study Valid? , 1994 .
[38] P. Vignati,et al. Preoperative evaluation and postoperative surveillance for patients with colorectal carcinoma. , 1993, The Surgical clinics of North America.
[39] C. Haglund,et al. CEA, CA 242, CA 19-9, CA 72-4 and hCGβ in the Diagnosis of Recurrent Colorectal Cancer , 2004, Tumor Biology.
[40] P. Bossuyt,et al. BMC Medical Research Methodology , 2002 .
[41] L E Moses,et al. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. , 1993, Statistics in medicine.
[42] P. Finan,et al. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. , 1994, British Journal of Cancer.
[43] C. Miki,et al. Combined Measurement of Hepatocyte Growth Factor and Carcinoembryonic Antigen as a Prognostic Marker for Patients with Dukes A and B Colorectal Cancer: Results of a Five-Year Study , 2006, Diseases of the colon and rectum.
[44] R. Molina,et al. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen. , 1997, Anticancer research.
[45] B. McNeil,et al. Assessment of radiologic tests: control of bias and other design considerations. , 1988, Radiology.
[46] R. Bergamaschi,et al. [Value of oncologic follow-up of patients operated for colorectal cancer. A prospective study of 1000 patients]. , 1997, Journal de Chirurgie.
[47] G. Guyatt,et al. Users ' Guides to the Medical Literature : III . How to Use an Article About a Diagnostic Test : A . Are the Results of the Study Valid ? , 2022 .
[48] J. Granell,et al. Evaluation of Serum Carcinoembryonic Antigen Monitoring in the follow-up of Colorectal Cancer Patients with Metastatic Lymph Nodes and a Normal Preoperative Serum Level , 1997, The International journal of biological markers.
[49] R. Klapdor,et al. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. , 1999, Anticancer research.
[50] L. Carey,et al. Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. , 1980, The Journal of surgical research.
[51] T R Fleming,et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. , 1993, JAMA.
[52] Frederick Mosteller,et al. Guidelines for Meta-analyses Evaluating Diagnostic Tests , 1994, Annals of Internal Medicine.
[53] P. Sammartino,et al. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences. , 1991, The Australian and New Zealand journal of surgery.
[54] T. Rockall,et al. Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer , 1999, International Journal of Colorectal Disease.
[55] D. Matos,et al. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. , 2006, World journal of gastroenterology.
[56] H. Schirrmeister,et al. Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? , 2000, American journal of surgery.
[57] Philipp Dahm,et al. Evidence-Based Surgery Chirurgie factuelle Users ’ guides to the surgical literature : how to use an article about a diagnostic test , 2001 .